Drugs / Xuefuzhuyu Decoction
Xuefuzhuyu Decoction
Trials 3 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2/31 trial | ||||||
| Phase 2/3 | NCT03167918 | Jul 2014 → Apr 2017 | type 2 diabetes mellitus | Liaoning University of Traditional Chinese Medicine | Completed | No outcome recorded |
| Phase 42 trials | ||||||
| Phase 4 | NCT03171597 | Aug 2017 → Oct 2019 | intermediate coronary syndrome | Jun Li | Unknown | No outcome recorded |
| Phase 4 | NCT03179618 | Jul 2017 → Oct 2019 | intermediate coronary syndrome | Jun Li | Unknown | No outcome recorded |
Evidence & citations 5 cited values
Every value below carries the sentence it was read from. 4 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Xuefuzhuyu Decoction | ClinicalTrials.gov intervention name — accepted as the source's own label NCT03167918 ↗ |
| Known as | XFZYT | “Objective. To evaluate the efficacy of Xuefu Zhuyu Tang (XFZYT) for treating angina pectoris (AP).” PMID 25254054 ↗ Aug 2014 |
| Known as | Xuefu Zhuyu Tang | “Objective. To evaluate the efficacy of Xuefu Zhuyu Tang (XFZYT) for treating angina pectoris (AP).” PMID 25254054 ↗ Aug 2014 |
| Modality | Traditional medicine (herbal / TCM) | “Xuefu Zhuyu Decoction has the function of activating qi and promoting blood circulation, which will be used to treat patients with qi stagnation and blood stasis syndrome.” NCT03179618 ↗ |
| Route | Oral | “Xuefuzhuyu Decoction 100 ml bid，po” NCT03167918 ↗ |